Voleon Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Buy
24,212
+17,639
+268% +$1.76M 0.05% 307
2025
Q4
$639K Buy
6,573
+1,515
+30% +$130K 0.01% 529
2025
Q3
$360K Sell
5,058
-110
-2% -$7.33K 0.01% 673
2025
Q2
$309K Sell
5,168
-3,927
-43% -$215K 0.02% 399
2025
Q1
$477K Sell
9,095
-5,521
-38% -$310K 0.04% 261
2024
Q4
$804K Buy
+14,616
New +$769K 0.06% 223

Other funds holding IRMD

Voleon Capital Management's IRMD Position: Q1 2026 in Review

Voleon Capital Management increased its iRadimed (IRMD) stake by 268% in Q1 2026, buying an estimated $1.76M and bringing the position to 24,212 shares worth $2.33M. The position accounts for 0.05% of the portfolio, ranked #307.

Voleon Capital Management first reported a position in IRMD in Q4 2024 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Voleon Capital Management held 24,212 shares of iRadimed worth $2.33M as of Q1 2026.
  • Voleon Capital Management bought 17,639 iRadimed shares in Q1 2026, an estimated $1.76M.
  • iRadimed made up 0.05% of Voleon Capital Management's portfolio in Q1 2026, its #307 holding.
  • Voleon Capital Management first reported a position in iRadimed in Q4 2024 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.